In this study, we tested the hypothesis that GLP1R perturbation has a protective effect on the risk of mood disorders (MDD and BD) using plasma GLP1R levels and glycated hemoglobin (HbA1c) levels. The gene discussed is GLP1R; the disease is major depressive disorder.